Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021

被引:0
作者
Lindboe, Johanne Bjerre [1 ,2 ,5 ]
Brynskov, Troels [1 ,3 ]
Sorensen, Torben Lykke [1 ,4 ]
Laugesen, Caroline Schmidt [1 ]
机构
[1] Zealand Univ Hosp, Dept Ophthalmol, Clin Eye Res Div, Roskilde, Denmark
[2] Univ Hosp Southern Denmark, Vejle Hosp, Dept Ophthalmol, Vejle, Denmark
[3] Copenhagen Univ Hosp, Dept Ophthalmol, Rigshosp Glostrup, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[5] Zealand Univ Hosp, Dept Ophthalmol, Clin Eye Res Div, Vestermarksvej 23, DK-4000 Roskilde, Denmark
关键词
D O I
10.1111/aos.16677
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:e661 / e662
页数:2
相关论文
共 3 条
[1]   Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting [J].
Brynskov, Troels ;
Laugesen, Caroline Schmidt ;
Sorensen, Torben Lykke .
ACTA OPHTHALMOLOGICA, 2013, 91 (03) :E243-E244
[2]   Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials [J].
Dugel, Pravin U. ;
Hillenkamp, Jost ;
Sivaprasad, Sobha ;
Voegeler, Jessica ;
Mousseau, Marie-Catherine ;
Wenzel, Andreas ;
Margaron, Philippe ;
Hashmonay, Ron ;
Massin, Pascale .
CLINICAL OPHTHALMOLOGY, 2016, 10 :1103-1110
[3]   Similar real-world two-year visual acuity gains in treatment-naive patients with diabetic macular oedema treated with a loading dose of three initial monthly injections versus less intensive regimens of intravitreal anti-vascular endothelial growth factor [J].
Lindboe, Johanne Bjerre ;
Schmidt Laugesen, Caroline ;
Sorensen, Torben Lykke ;
Brynskov, Troels .
ACTA OPHTHALMOLOGICA, 2021, 99 (07) :E1248-E1249